News
20mon MSN
The Supreme Court is ruling more frequently in favor of religious groups. Are mainstream Christians coming out ahead?
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines ProgramAgios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results